Cited by 106COVID-19 and Mental HealthLong-Term Effects of COVID-19Olfactory and Sensory Function Studies

Mood, Anxiety and Olfactory Dysfunction in COVID‐19: Evidence of Central Nervous System Involvement?

Open access
Speth, Marlene M., Singer‐Cornelius, Thirza, Oberle, Michael, Gengler, Isabelle, Brockmeier, Steffi J., Sedaghat, Ahmad R.·2020·The Laryngoscope

Abstract

Objective: The objective of this study was to determine the burden of depressed mood and anxiety in COVID‐19, and associated disease characteristics. Materials and Methods: This is a prospective, cross‐sectional study of 114 COVID‐19 positive patients diagnosed using RT‐PCR‐based testing over a 6‐week period. The two‐item Patient Health Questionnaire (PHQ‐2) and the two‐item Generalized Anxiety Disorder questionnaire (GAD‐2) were used to measure depressed mood and anxiety level, respectively, at enrollment and for participants' baseline, pre‐COVID‐19 state. Severity of smell loss, loss of taste, nasal obstruction, rhinorrhea/mucus production, fever, cough, and shortness of breath (SOB) during COVID‐19 were assessed. Results: PHQ‐2 and GAD‐2 significantly (P < .001) increased from baseline to enrollment. PHQ‐2 was associated with smell loss (adjusted incidence rate ratio [aIRR] = 1.40, 95% CI, 1.10–1.78, P = .006), age (aIRR = 1.02, 95% CI, 1.01–1.04, P = .006), and baseline PHQ‐2 score (aIRR = 1.39, 95% CI, 1.09–1.76, P = .007). GAD‐2 score was associated with smell loss (aIRR = 1.29, 95% CI, 1.02–1.62, P = .035), age (aIRR = 1.02, 95% CI, 1.01–1.04, P = .025) and baseline GAD‐2 score (aIRR = 1.55, 95% CI, 1.24–1.93, P < .001). Loss of taste also exhibited similar associations with PHQ‐2 and GAD‐2. PHQ‐2 and GAD‐2 scores were not associated with severities of any other symptoms during the COVID‐19 course. Conclusions: Despite the occurrence of symptoms—such as SOB—associated with severe manifestations of COVID‐19, only the severities of smell and taste loss were associated with depressed mood and anxiety. These results may raise the novel possibility of emotional disturbance as a CNS manifestation of COVID‐19 given trans‐olfactory tract penetration of the central nervous system (CNS) by coronaviruses. Level of Evidence: 3 Laryngoscope, 130:2520–2525, 2020

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/lary.28964

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Speth, M. M., Singer‐Cornelius, T., Oberle, M., Gengler, I., Brockmeier, S. J., & Sedaghat, A. R.
Affiliations
  • Kantonsspital Aarau (CH)
  • University of Cincinnati (US)
Corresponding author
Sedaghat, Ahmad R.
Venue
The Laryngoscope
Publisher
Wiley
Published
2020-08-12
Volume
130
Issue
11
Pages
2520-2525
ISSN
  • 0023-852X (ISSN-L)
  • 1531-4995
OpenAlex
W3039679645
Cited by
106
References
44
Citations by year
2026: 3 · 2025: 7 · 2024: 11 · 2023: 13 · 2022: 24 · 2021: 36 · 2020: 11
FWCI
8.38
Type
journal article
Language
en
Open access
Locations
  • The Laryngoscope (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
Keywords
COVID-19 pandemic, depression, anxiety, olfactory dysfunction, anosmia, ageusia, central nervous system involvement, psychiatric comorbidity, PHQ-2, GAD-2, age as risk factor, dyspnea, nasal obstruction, rhinorrhea, fever, cough, symptom severity
MeSH terms
COVID-19, SARS-CoV-2, Adult, Aged, Olfaction Disorders, Anxiety, Central Nervous System, Cross-Sectional Studies, Depression, Female, Humans, Male, Middle Aged, Prospective Studies, Severity of Illness Index, Taste Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review